UNSPSC 51351509: Medroxyprogesterone

This classification denotes a therapeutic progestin with the molecular formula C22H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HSU1C9YRES, chemically known as 17-hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione but generally known as medroxyprogesterone, which bears US NIH Compound Identifier 10631. European Medicines Agency schedules Medroxyprogesterone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08699MIG.

UNSPSC 51351509 Medroxyprogesterone, a Commodity code, identifies a specific pharmaceutical product — the progestin medroxyprogesterone acetate (MPA) — that state and local governments procure primarily through health departments, school districts offering student health services, county clinics, and corrections departments. The product is sourced as an injectable contraceptive (Depo-Provera) or an oral tablet formulation and is purchased in bulk for distribution through public health clinics, family planning programs, correctional health services, and school-based health centers. Issuing bodies include state health and human services departments, county health departments, municipal public health agencies, and independent school districts with student health programs.

The source material provided contains no recent state and local contract opportunities tagged to this code, precluding characterization of geographic spread or identification of representative solicitations. Without posted RFPs, RFQs, IBFs, or ITBs naming this commodity code, evaluation of current procurement velocity, issuing-body concentration, or response timelines is not supported by the available data.